189 results
Page 5 of 10
8-K
EX-99.2
1vkn1 u20zjve
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
63qwsnka3mw88kn42tn
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
aj65h2b9zjdz
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
ggw2zwfydh8mg
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
fbym94
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.4
c1a22i 45eix1yju
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
sjae6sz7pdxu
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.2
s4lb4u
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
mh9h jjfr0q6boqwg6o
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
3ocb8499
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
u0lfkd9i856yjl3ttl
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.2
bvdz fpi1cyaeeic
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
lb837bdyc14w9wky2r9u
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm